- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 39/015 - Hemosporidia antigens, e.g. Plasmodium antigens
Patent holdings for IPC class A61K 39/015
Total number of patents in this class: 624
10-year publication summary
44
|
44
|
50
|
51
|
34
|
47
|
41
|
28
|
27
|
15
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Glaxosmithkline Biologicals S.A. | 1701 |
27 |
Institut Pasteur | 798 |
19 |
Oxford University Innovation Limited | 1421 |
19 |
Sanaria Inc. | 36 |
18 |
The United States of America, as represented by the Secretary, Department of Health and Human Services | 2737 |
17 |
Artificial Cell Technologies, Inc. | 38 |
15 |
The United States of America as represented by the Secretary of the Navy | 2734 |
10 |
Isis Innovation Limited | 543 |
10 |
Leidos, Inc. | 205 |
10 |
The Trustees of the University of Pennsylvania | 4122 |
9 |
The United States of America as represented by the Secretary of the Army | 1195 |
8 |
GenVec, Inc. | 64 |
8 |
Rhode Island Hospital | 182 |
8 |
Board of Trustees of the University of Arkansas | 771 |
7 |
Griffith University | 143 |
7 |
Modernatx, Inc. | 1181 |
7 |
Seattle Children's Hospital, d/b/a Seattle Children's Research Institute | 93 |
7 |
The Texas a & M University System | 1519 |
7 |
University of Washington | 2157 |
7 |
The Walter and Eliza Hall Institute of Medical Research | 170 |
7 |
Other owners | 397 |